Discovery of PEN-221, an SSTR2-targeting maytansinoid conjugate with potent activity in vitro and in vivo

被引：0
|
作者：
White, Brian H.
Bazinet, Patrick
Whalen, Kerry
DuPont, Michelle
Quinn, James M.
Alargova, Rossitza
Yeung, Tsun Au
Brockman, Adam
Gifford, James
Oller, Haley
Kriksciukaite, Kristina
Lemelin, Charles-Andre
Soo, Patrick Lim
Moreau, Benoit
Perino, Samantha
Sharma, Gitanjali
Shinde, Rajesh
Sweryda-Krawiec, Beata
Simcox, Mary
Wooster, Richard
Bilodeau, Mark T.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-39
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
39
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Discovery of an SSTR2-Targeting Maytansinoid Conjugate (PEN-221) with Potent Activity in Vitro and in Vivo
    White, Brian H.
    Whalen, Kerry
    Kriksciukaite, Kristina
    Alargova, Rossitza
    Yeung, Tsun Au
    Bazinet, Patrick
    Brockman, Adam
    DuPont, Michelle
    Oller, Haley
    Lemelin, Charles-Andre
    Soo, Patrick Lim
    Moreau, Benoit
    Perino, Samantha
    Quinn, James M.
    Sharma, Gitanjali
    Shinde, Rajesh
    Sweryda-Krawiec, Beata
    Wooster, Richard
    Bilodeau, Mark T.
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (05) : 2708 - 2719
  • [2] Targeting the Somatostatin Receptor 2 with the Miniaturized Drug Conjugate, PEN-221: A Potent and Novel Therapeutic for the Treatment of Small Cell Lung Cancer
    Whalen, Kerry A.
    White, Brian H.
    Quinn, James M.
    Kriksciukaite, Kristina
    Alargova, Rossitza
    Yeung, Tsun P. Au
    Bazinet, Patrick
    Brockman, Adam
    DuPont, Michelle M.
    Oller, Haley
    Gifford, James
    Lemelin, Charles-Andre
    Soo, Patrick Lim
    Perino, Samantha
    Moreau, Benoit
    Sharma, Gitanjali
    Shinde, Rajesh
    Sweryda-Krawiec, Beata
    Bilodeau, Mark T.
    Wooster, Richard
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (11) : 1926 - 1936
  • [3] Epigenetic modulation of SSTR2 expression provides the potential to broaden PEN-221 treatment population
    Perino, Samantha
    Quinn, James
    Freda, Jessica
    White, Brian
    Bailey, Scott
    Bhatia, Viren
    Sweryda-Krawiec, Beata
    Bilodeau, Mark
    Bloss, Jeffrey D.
    Whalen, Kerry
    Wooster, Richard
    CANCER RESEARCH, 2019, 79 (13)
  • [4] The Pentarin Miniaturized Drug Conjugate PEN-221 Targets the Potent Cytotoxic DM1 to Somatostatin Receptor 2 Expressing Cancers
    Whalen, Kerry
    White, Brian
    Kriksciukaite, Kristina
    Yeung, Tsun Au
    Bazinet, Patrick
    Callahan, Kay
    DuPont, Michelle
    Gifford, Jamie
    Moreau, Benoit
    Perino, Sam
    Quinn, James
    Sharma, Gitanjali
    Shinde, Rajesh
    Sweryda-Krawiec, Beata
    Alland, Leilla
    Simcox, Mary
    Bilodeau, Mark
    Wooster, Richard
    PANCREAS, 2017, 46 (03) : 429 - 430
  • [5] IMGN529 is an anti-CD37-maytansinoid conjugate with potent in vitro and in vivo activity against NHL and CLL cell lines
    Mayo, Michele F.
    Li, Min
    Yi, Yong
    Xu, Shanqin
    Lai, Katharine C.
    Erickson, Hans K.
    Deckert, Jutta
    Park, Peter U.
    Lutz, Robert J.
    Pinkas, Jan
    CANCER RESEARCH, 2011, 71
  • [6] MED14276, a HER2-targeting antibody tubulysin conjugate, displays potent in vitro and in vivo activity in preclinical studies
    Li, John
    Toader, Dorin
    Perry, Samuel R.
    Muniz-Medina, Vanessa
    Wetzel, Leslie
    Rebelatto, Marlon C.
    Hinrichs, Mary Jane Masson
    Fleming, Ryan
    Bezabeh, Binyam
    Thompson, Pamela
    Dimasi, Nazzareno
    Lam, Brandon
    Yu, Xian-Qing
    Gao, Changshou
    Dixit, Rakesh
    Coats, Steven
    Osbourn, Jane
    Wu, Herren
    CANCER RESEARCH, 2016, 76
  • [7] In vitro and in vivo activity of a highly potent and novel FGFR2/FGFR4 dual targeting antibody-drug conjugate
    Meyer, Matthew J.
    Jenkins, David
    Batt, David
    Mosher, Rebecca
    Isaacs, Randi
    Hu, Tiancen
    Capka, Vladimir
    Zhang, Xiamei
    Chen, Dongshu
    Tang, Lujia
    Daley, Mike
    Nowakowski, Patrycja
    Shim, Yeonju
    Jiang, Wei
    Ettenberg, Seth
    Lees, Emma
    CANCER RESEARCH, 2015, 75
  • [8] Discovery of novel KSP-targeting PROTACs with potent antitumor effects in vitro and in vivo
    Zhao, Deng-Gao
    Liu, Jieying
    Su, Zhengxi
    Zou, Wenbo
    Zhou, Qianwei
    Yin, Ting
    Jiyao, Tan
    Ma, Yan-Yan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 282
  • [9] Discovery of a novel natural product inhibitor of Clostridioides difficile with potent activity in vitro and in vivo
    Pal, Rusha
    Seleem, Mohamed N.
    PLOS ONE, 2022, 17 (08):
  • [10] Discovery of Novel 8-Hydroxyquinoline Derivatives with Potent In Vitro and In Vivo Antifungal Activity
    Li, Liping
    Wu, Hao
    Wang, Jiayin
    Ji, Zhe
    Fang, Ting
    Lu, Hui
    Yan, Lan
    Shen, Fuming
    Zhang, Dazhi
    Jiang, Yuanying
    Ni, Tingjunhong
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (23) : 16364 - 16376
12345